Ani Pharmaceuticals (ANIP) Price to Book (2013 - 2026)

Ani Pharmaceuticals has disclosed Price to Book across 14 years of filings, most recently posting 3.31 for Q2 2026.

• In Q2 2026, Price to Book fell 0.86% year-over-year to 3.31; the TTM figure through Jun 2026 stood at 3.31 (down 0.86% YoY), while the FY2025 annual figure was 3.28, up 13.59% from the prior year.
• Price to Book came in at 3.31 for Q2 2026 at Ani Pharmaceuticals, up from 3.25 in the prior quarter.
• In the past five years, Price to Book ranged from a high of 4.18 in Q3 2025 to a low of 1.51 in Q1 2022.
• Average Price to Book over 5 years is 2.82, with a median of 2.95 recorded in 2024.
• Year-over-year, Price to Book plunged 33.04% in 2022 and surged 61.03% in 2023.
• Over 5 years, Price to Book stood at 2.24 in 2022, then gained by 17.7% to 2.64 in 2023, then increased by 9.43% to 2.89 in 2024, then increased by 13.59% to 3.28 in 2025, then increased by 0.69% to 3.31 in 2026.
• Per Business Quant data, the three most recent Price to Book figures were 3.31 in Q2 2026, 3.25 in Q1 2026, and 3.28 in Q4 2025.